We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
A premium food delivery service, SUPPER uses custom-built temperature controlled bikes to ensure perfect deliveries for restaurants ranging from Michelin starred to quality casual. 
days to go: Expired investment: £206,630
Recap is a cryptocurrency portfolio tracking, analytics and tax reporting platform. The company claims that market participants engaging in cryptocurrency have to deal with complex issues such as tracking all of their transactions, valuing cryptocurrency transactions in their tax currency and understanding capital gains tax legislation laws. Recap aims to solve this issue by enabling said participants to calculate any tax they owe on their cryptocurrency trading activity in a matter of seconds on its portal. The company has plans to launch a mobile application enabling investors to track their portfolio on the move. It also intends to come up with a Business-to-business (B2B) offering which Recap asserts will enable crypto native companies to account for their cryptocurrency activity with automatic accounts reconciliation to accounting software like Xero and Quickbooks. The company’s exit strategy is a trade sale within 3-5 years to a cryptocurrency exchange or accounting software provider.

Pitch Rated

84%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £120,472
Fireaway pizza orginally started out as a modest pizzeria in south London in 2016, we've expanded to 159 franchises, achieving a remarkable 106% compound annual growth rate in store expansion. With franchise sales reaching £59 million annually, we became debt-free in 2022, boasting an EBITDA of £1.31 million and HQ revenue of £14.5 million in FY23. As a profitable venture, we invite you to join us and be part of our promising growth trajectory.
days to go: Expired investment: £532,336
Laka Insurance is a collective insurance provider. The company is disrupting the cycling and e-mobility industry. It aims to become a segment leader in the aforementioned industry that is forecast to reach £100 billion by 2025. Laka argues that the traditional insurance model is based on insurers taking a customer's money and profiting from not paying out claims. It aims to change this. Members on Laka share the cost of all claims, and the company earns its share when settling claims for the member. Laka has insured over 10,000 bikes till date. The company launched its new product, Laka Club, in 2020 that offers third-party liability insurance. Laka has won the Best Cycle Insurance Provider at the Insurance Choice Awards multiple times. The company will use the investment to expand its customer base, bring new offerings, and expand its business across different demographics.
days to go: Expired investment: £2,056,630
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph